K Number
K011842
Device Name
SABRE COMPAC
Manufacturer
Date Cleared
2002-01-08

(210 days)

Product Code
Regulation Number
882.1900
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The SABRe Compac Auditory Brainstem Response Screener is a device that produces a sound stimulus for use in evoked response measurements. It is intended to be used by trained professionals in the determination of hearing disorders.
Device Description
The SABRe Compac ABR Screener is an evoked potential device to be used in the diagnosis of hearing disorders.
More Information

Not Found

No
The summary does not mention AI, ML, or any related terms, and the device description is consistent with a standard evoked potential device.

Yes
The device is used to determine hearing disorders and aid in diagnosis, which are therapeutic purposes.

Yes
The device description explicitly states, "The SABRe Compac ABR Screener is an evoked potential device to be used in the diagnosis of hearing disorders." Additionally, the intended use section mentions its role "in the determination of hearing disorders," which is a diagnostic function.

No

The description explicitly states the device "produces a sound stimulus," which implies a hardware component is involved in generating the sound. Software alone cannot produce a physical sound stimulus.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue taken from the human body to detect diseases or other conditions.
  • Device Function: The SABRe Compac Auditory Brainstem Response Screener produces a sound stimulus and measures evoked responses. This is a non-invasive procedure that does not involve testing samples taken from the body.
  • Intended Use: The intended use is for the determination of hearing disorders by trained professionals, which is a diagnostic process, but not one that relies on in vitro testing.

Therefore, the device falls under the category of a diagnostic device, but specifically an in vivo diagnostic device, as it interacts directly with the patient's body (through sound stimulation and measurement of physiological responses) rather than testing samples outside the body.

N/A

Intended Use / Indications for Use

The SABRe Compac Auditory Brainstem Response Screener is a device that produces a sound stimulus for use in evoked response measurements. It is intended to be used by trained professionals in the determination of hearing disorders.

Product codes

84 GWJ

Device Description

The SABRe Compac ABR Screener is an evoked potential device to be used in the diagnosis of hearing disorders.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

trained professionals

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K993177

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 882.1900 Evoked response auditory stimulator.

(a)
Identification. An evoked response auditory stimulator is a device that produces a sound stimulus for use in evoked response measurements or electroencephalogram activation.(b)
Classification. Class II (performance standards).

0

K011842

8 2002 JAN

510(K) SUMMARY

Manufacturer:

SLE Limited Diagnostics Group Twin Bridges Business Park 232 Selsdon Road South Croydon Surrey CR2 6PL United Kingdom

Submitted By:

Ferguson Medical Consultant to SLE

Stimulator, Auditory, Evoked Response Classification Name:

  • Hearing Screener, Auditory Screener, Auditory Common/Usual Name: Brainstem Response Screener, and others.
  • Proprietary Name: SABRe Compac

Classification Number: 21 CFR 882.1900/Procode: 84 GWJ

SLE SABRE ABR Screener (K993177) Substantial Equivalence:

Device Description: The SABRe Compac ABR Screener is an evoked potential device to be used in the diagnosis of hearing disorders.

  • The SABRe Compac Auditory Brainstem Response Screener Intended Use: is a device that produces a sound stimulus for use in evoked response measurements. It is intended to be used by trained professionals in the determination of hearing disorders.
    Technological Characteristics: The SABRe Compac ABR device is similar in its intended use to predicate devices and existent methodologies.

1

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

8 2002 JAN

SLE Limited c/o Frank Ferguson Ferguson Medical P. O. Box 12038 La Jolla, California 92039-2038

Re: K011842 Trade Name: SABRe Compac Regulation Number: 882.1900 Regulation Name: Evoked Response Auditory Stimulator Regulatory Class: II Product Code: GWJ Dated: November 25, 2001 Received: December 10, 2001

Dear Mr. Ferguson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

2

Page 2 - Mr. Frank Ferguson

This letter will allow you to begin marketing your device as described in your Section Fills letter will anow you to began a Finding of substantial equivalence of your 510(k) premiation nourceation. The results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 II you desire specific ad 1100 for in vitro diagnostic devices), please contact the and additionally 21 OFF are 004-4659. Additionally, for questions on the promotion Office of Comphance at (evice, please contact the Office of Compliance at (301) 594and advertising of your do regulation entitled, (Misbranding by reference to premation 4059. Also, prease note all regariances information on your responsibilities nourceation((210) {{210} {{ } {{ } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } and Consumer Assistance at its toll-free number (800) 6382041 or (301) 4436597 or at its aller Collistmer I issuese ank http://www.fda.gov/cdrh/dsma/dsmamain.html http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Stupt Rhodes

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

510(k) Number (If known): Koll & 4 L

Device Name: SABRe Compac

Indications For Use:

The SABRe Compac Auditory Brainstem Response Screener is a device that produces a sound stimulus for use in evoked response measurements. It is intended to be used by trained professionals in the determination of hearing disorders.

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation (ODE)

Hyatt Riveles

(Division Sign-Off) Division of General, Restorative and Neurological Devices

510(k) Number_________________________________________________________________________________________________________________________________________________________________

Prescription Use __ XX -(Per 21 CFR 801.109)

OR

Over-The- Counter Use ________________________________________________________________________________________________________________________________________________________